What entities are conscious and how could we ever know? We recently provided a framework for developing validated tests for consciousness (‘C-tests’): the Iterative Natural Kind Strategy (INKS) [1]. Brown and colleagues [2] raise some important questions for the INKS approach, although we are not sure how different their answers to those questions are from […]
Published on August 23, 2024
How can we validate tests for consciousness beyond healthy adult humans? Bayne and colleagues propose the ‘iterative natural kind strategy’ (INKS) [1]. INKS begins by taking seriously all tests with at least some face validity rather than restricting our attention to a small subset of tests that antecedently pass stringent requirements of validation. We then […]
Published on August 23, 2024
A new type of cancer drug might help treat brain diseases like Alzheimer’s, mouse studies suggest. The drugs block an enzyme called indoleamine-2,3-dioxygenase 1 (IDO1), researchers reported. IDO1 inhibitors are being developed as a treatment for cancers like melanoma,… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]
Published on August 23, 2024